Stocks and Investing Stocks and Investing
Tue, November 8, 2022
Mon, November 7, 2022

Mani Foroohar Maintained (BEAM) at Buy with Decreased Target to $81 on, Nov 7th, 2022


Published on 2024-10-27 23:59:50 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Decreased Target from $82 to $81 on, Nov 7th, 2022.

Mani has made no other calls on BEAM in the last 4 months.



There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, 1 agrees with Mani's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $60 on, Wednesday, August 10th, 2022


This is the rating of the analyst that currently disagrees with Mani


  • Rick Bienkowski of "SVB Leerink" Maintained at Buy with Decreased Target to $113 on, Wednesday, August 10th, 2022

Contributing Sources